Byotrol PLC operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Byotrol PLC with three other
pharmaceutical manufacturers in Europe:
Collagen Solutions PLC
sales of £3.13 million [US$3.83 million]
Nuevolution AB (publ)
(21.31 million Swedish Kronor [US$2.39 million]
Oasmia Pharmaceutical AB
based in Sweden
(6.37 million Swedish Kronor [US$715,178.06 ]
During the year ended March of 2016, sales at
Byotrol PLC were £2.65 million (US$3.24 million).
decrease of 18.6%
versus 2015, when the company's sales were £3.25 million.
Contributing to the drop in overall sales was the 29.2% decline
in Professional, from £2.02 million to £1.43 million.
There were also decreases in sales in
Pet (down 26.5% to £689,832.00 )
However, these declines were partially offset by the increase in sales of
Consumer (up 80.8% to £527,521.00 )